China Regenerative Medicine International Limited (8158.HK)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Chuang Wang | CEO, Executive Chairman & Compliance Officer | 1.2M | -- | 1979 |
| Mr. Po Tin Wong | Chief Financial Officer | -- | -- | -- |
| Dr. Xiaohu Sun | Chief Operating Officer | -- | -- | 1965 |
| Dr. Jinnan Zhang | Chief Technology Officer | -- | -- | 1985 |
| Mr. Wing Nin Ip | Legal Counsel | -- | -- | -- |
| Dr. Zhanfeng Cui Freng | Chairman of Stem Cell Division & Director of University of Oxford Tissue Engineering Centre | 500k | -- | 1963 |
| Mr. Wun Fat Khoo | Company Secretary | -- | -- | 1981 |
China Regenerative Medicine International Limited
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 46
Description
China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People's Republic of China. The company offers various health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services, including non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate rejuvenation treatment services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
Corporate Governance
Recent Events
- Sep 24, 2002Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available